Given the ever-increasing prices of new drugs,1 the use of health technology assessment (HTA) by healthcare payers and insurers for guiding reimbursement and pricing decisions is becoming increasingly important for the …
Blog
-
-
The Innovative Medicines Fund (IMF) represents a significant stride in healthcare accessibility, stemming from the triumph of its predecessor, the Cancer Drugs Fund (CDF). Launched in June 2022, the IMF extends its …
-
We have been using QALYS since I was 18 since it was vigorously defended by Alan Williams In late March, the House Committee on Energy and Commerce made significant strides by advancing …
-
The journey from drug discovery to market approval is complex and time-consuming, often taking over a decade and billions of dollars. In response to the urgent need for treatments addressing severe or …
-
The realm of orphan medicines, dedicated to addressing rare diseases affecting a fraction of the population, stands at a crossroads marked by regulatory gaps and uncertainties. As stakeholders navigate this intricate landscape, …
-
In the realm of neuroradiology and neurology, a groundbreaking shift has emerged with the introduction of new CPT codes, 0865T and 0866T, by icometrix. These codes herald a transformative era, providing a …
-
A decade ago, a surge of companies emerged with the promise of revolutionizing personal health through data tracking of habits like eating, sleep, and exercise. Among these, Zeo, a standout startup, garnered …
-
In recent years, the healthcare landscape has undergone a profound transformation, with a significant shift towards patient-centric care. Among the most promising innovations driving this change is the emergence of virtual wards …
+44 (0) 7804 623 339
Unit 1-2
Field View Business Park
Bicester
UNITED KINGDOM
OX27 7SG
15 Rue de President Roosevelt
Pons
FRANCE
17800